Background Non-stenotic carotid plaque is considered an important etiology of embolic
stroke of undetermined source (ESUS). However, only a few previous studies included a …

Background and aims Patients with embolic strokes of undetermined source (ESUS) usually
present with mild symptoms. We aimed to compare the baseline characteristics between …

Background The identification of the underlying mechanism in ischemic stroke has important
implications for secondary prevention. A disintegrin and metalloprotease with a …

Background Atrial cardiopathy (AC) has emerged as a potential pathological thrombogenic
atrial substract of embolic stroke of undetermined source (ESUS), even in the absence of …

Background More than half of patients with embolic stroke of undetermined source (ESUS)
suffer from recurrent ischaemic stroke, despite the absence of atrial fibrillation (AF) on …

Introduction Implantable loop recorders (ILR) are used to screen for atrial fibrillation (AF) in
patients with cryptogenic stroke (CS). However, there is limited real‐world data regarding …

Background Reports of the clinical outcomes associated with the co-occurrence of atrial
cardiomyopathy (ACM) and lung cancer (LC) are limited. Objectives This study aims to …

Background Embolic stroke of undetermined source (ESUS) accounts for up to 25% of
strokes. Understanding risk factors associated with ESUS is important in reducing stroke …

Представлен клинический разбор пациентки молодого возраста с рецидивирующими
ишемическими инсультами. Обсуждаются проблемы диагностики эмболических …

Abstract Background & Objectives: Despite recent scientific advances in acute ischemic
stroke treatment, there has been limited progress for the secondary prevention of …